Pioglitazone: reports of its death are greatly exaggerated – it is alive and ready to resume saving lives

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|32|4|e9-e15

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.4, 2015-04, pp. : e9-e15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone: are rumours of its death exaggerated?

By  

DIABETIC MEDICINE, Vol. 32, Iss. 4, 2015-04 ,pp. : 431-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

The glycemic index: Reports of its demise have been exaggerated

By  

OBESITY, Vol. 23, Iss. 7, 2015-07 ,pp. : 1327-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Saving lives with alternative medicine research?

By  

FOCUS ON ALTERNATIVE AND COMPLEMENTARY THERAPIES AN EVIDENCE-BASED APPROACH, Vol. 20, Iss. 2, 2015-06 ,pp. : 57-57

John Wiley & Sons Inc

Access to resources Recommend Favorite

Death, lives, and video streams

By O'Neill Kevin  

Mortality, Vol. 13, Iss. 2, 2008-05 ,pp. : 174-186

Routledge Ltd

Access to resources Recommend Favorite

Saving babies’ lives by antenatal malaria prevention

By Rogerson Stephen J  

Pathogens and Global Health, Vol. 107, Iss. 2, 2013-03 ,pp. : 46-46

Maney Publishing

Access to resources Recommend Favorite